ORI Updates

ORI found that Johnny J. He, Ph.D., who is a Professor, Department of Microbiology and Immunology, RFUMS, engaged in research misconduct in research reported in grant applications submitted for U.S. Public Health Service (PHS) funds, specifically the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), National Institute on Aging (NIA), NIH, and National Institute of Neurological Disorders and Stroke (NINDS), NIH.

The Office of Research Integrity, Office of the Assistant Secretary for Health has posted an Expression of Interest for a Research Integrity Specialist.

ORI found that Carlo Spirli, Ph.D., who was an Assistant Professor of Medicine, Department of Digestive Diseases, YU, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH).

ORI has released two notice of funding opportunity announcements for projects, conferences, and workshops that advance the evolving field of research integrity and produce tangible outcomes related to ensuring the integrity and reliability of Public Health Service funded research.

The ORI FY 2022 Annual Report is now available.

The Office of Research Integrity is seeking highly qualified candidates for two positions: a Scientist-Investigator position within the Division of Investigative Oversight and an Education and Integrity Specialist position within the Division of Education and Integrity.

We are pleased to announce that Sheila Garrity, JD, MPH, MBA will be joining ORI in March as the new Director.

ORI found that Alice C. Chang, Ph.D. (formerly named Chun-Ju Chang), who was an Associate Professor of Basic Medical Sciences, College of Veterinary Medicine, PU, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH).

ORI found that Douglas D. Taylor, Ph.D. (Respondent), former Professor and Vice Chair for Research, Department of Obstetrics & Gynecology, UL, engaged in research misconduct under 42 C.F.R. Part 93 in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH).

ORI thanks everyone who responded to the RFI. There will be additional opportunities to comment during the rulemaking process.